3-98799515-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080927.4(DCBLD2):c.2185C>A(p.Gln729Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080927.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DCBLD2 | NM_080927.4 | c.2185C>A | p.Gln729Lys | missense_variant | 16/16 | ENST00000326840.11 | |
DCBLD2 | XM_011512419.3 | c.1957C>A | p.Gln653Lys | missense_variant | 15/15 | ||
DCBLD2 | XM_024453348.2 | c.1867C>A | p.Gln623Lys | missense_variant | 16/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DCBLD2 | ENST00000326840.11 | c.2185C>A | p.Gln729Lys | missense_variant | 16/16 | 1 | NM_080927.4 | P1 | |
DCBLD2 | ENST00000326857.9 | c.2227C>A | p.Gln743Lys | missense_variant | 16/16 | 1 | |||
ST3GAL6 | ENST00000491912.1 | n.254-1907G>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000723 AC: 18AN: 249046Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135098
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461702Hom.: 0 Cov.: 32 AF XY: 0.0000344 AC XY: 25AN XY: 727132
GnomAD4 genome AF: 0.000328 AC: 50AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.000322 AC XY: 24AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.2185C>A (p.Q729K) alteration is located in exon 16 (coding exon 16) of the DCBLD2 gene. This alteration results from a C to A substitution at nucleotide position 2185, causing the glutamine (Q) at amino acid position 729 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at